论文部分内容阅读
目的观察辛夷鼻炎丸在慢性肥厚性鼻炎低温等离子射频消融术后应用的疗效。方法将110例慢性肥厚性鼻炎并接受鼻内镜下等离子射频消融术的患者分为试验组和对照组各55例,术后均在应用抗生素+鼻类固醇激素治疗的基础上,试验组口服辛夷鼻炎丸,对照组口服维生素类药物,术后随访1个月。分别于术前及术后2周、1个月应用视觉模拟评分法(VAS)评价鼻塞的主观感觉,并观察术后鼻腔黏膜肿胀情况。结果试验组患者和对照组患者术前鼻塞VAS评分为(7.36±0.99)分和(7.35±0.75)分,术后2周VAS评分为(4.25±1.04)分和(5.18±1.32)分,术后1个月VAS评分为(2.51±1.25)分和(3.16±1.32)分。术后2周及1个月组间疗效比较差异有显著统计学意义(P<0.05)。结论辛夷鼻炎丸是慢性肥厚性鼻炎低温等离子射频消融术后较好的辅助用药。
Objective To observe the curative effect of Xinyi-rhodanitis pill after low temperature plasma radiofrequency ablation of chronic hypertrophic rhinitis. Methods One hundred and ten patients with chronic hypertrophic rhinitis undergoing endoscopic nasal plasma radio-frequency ablation were divided into experimental group and control group (n = 55). All patients were treated with antibiotics and nasal steroids after operation. Rhinitis pills, the control group oral vitamin drugs, followed up for 1 month. The subjective sensation of nasal obstruction was evaluated preoperatively and 2 weeks and 1 month after operation by visual analogue scale (VAS), and postoperative nasal mucosal swelling was observed. Results The VAS score of preoperative nasal obstruction was (7.36 ± 0.99) points and (7.35 ± 0.75) points respectively in the experimental group and control group. The VAS score was (4.25 ± 1.04) and (5.18 ± 1.32) points VAS score was (2.51 ± 1.25) points and (3.16 ± 1.32) points after 1 month. There were significant differences in the curative effect between two weeks and one month after operation (P <0.05). Conclusion Xinyi rhinitis pill is a good adjuvant for chronic hypertrophic rhinitis after radiofrequency ablation of low temperature plasma.